Inhaleret humant insulin har glucosesænkende virkningsvarighed sammenlignelig med subkutant indgivet hurtigtvirkende humant insulin og længere end hurtigtvirkende insulin- analoger (se figur 1). t le
Inhaled human insulin has a duration of glucose lowering activity comparable to subcutaneously administered fast-acting human insulin and longer than fast-acting insulin analogues (see Figure 1).